⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALT News
Altimmune, Inc. Common Stock
Form 8-K
sec.gov
ALT
Altimmune Announces Fourth Quarter and Full-year 2025 Financial Results and Business Updates
globenewswire.com
ALT
Altimmune to Participate in Upcoming Investor Conferences
globenewswire.com
ALT
Altimmune to Participate in Upcoming Investor Conferences
globenewswire.com
ALT
Altimmune to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026
globenewswire.com
ALT
Secura Bio Expands Chief Financial Officer Will Brown’s Leadership Role to Include Chief Operating Officer
globenewswire.com
SBIO
ALT
Altimmune Announces Closing of $75 Million Registered Direct Offering of Common Stock
globenewswire.com
ALT
Longevity Biotech Stocks Surge as $27 Trillion Healthcare Shift Favors Cell Restoration
prnewswire.com
ALT
ARWR
MNKD
LCTX
Altimmune Announces Pricing of $75 Million Registered Direct Offering of Common Stock
globenewswire.com
ALT
Altimmune Receives FDA Breakthrough Therapy Designation for Pemvidutide in MASH
globenewswire.com
ALT